MIRA INFORM REPORT

 

 

Report No. :

355692

Report Date :

24.12.2015

 

IDENTIFICATION DETAILS

 

Name :

SRS PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

601-605, 6th Floor, Marathon Max Building No. 2, L.B.S. Marg, Mulund (West), Mumbai - 400080, Maharashtra

Tel. No.:

91-22-41577000 

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

27.03.2001

 

 

Com. Reg. No.:

11-131384

 

 

Capital Investment / Paid-up Capital :

Rs. 50.000 Million

 

 

CIN No.:

[Company Identification No.]

U24239MH2001PTC131384

 

 

IEC No.:

0390022691

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAFCS4633P 

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Supplier of wide range of avant-garde Pharmaceuticals. (Confirmed by Management)

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (50)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 967700

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was established in the year 2001 and it is engaged in manufacturing and supplying of finished formulations, herbal formulations and direct compression granules. Its products include cefixime and lactobacillus comination, esomeprazole for injection, imipenem and cilastatin sodium for injection, piperacillin sodium and tazobactam for injection.

 

Rating takes into consideration company’s established track record of business operations supported by its satisfactory financial profile along with sound debt coverage indicators and moderate liquidity position.

 

However, rating strength is partially offset by working capital nature of business operations and susceptibility to fluctuation in raw material prices impacting volatility to profitability.

 

Trade relations are reported as fair. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTE:

Management of the company has not filed its financial with Government Department for the year 2015 and same are not available from any sources.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Anjan Shah

Designation :

Finance Department

Contact No.:

91-22-41577000

Date :

18.12.2015

 

 

LOCATIONS

 

Registered Office :

601-605, 6th Floor, Marathon Max Building No. 2, L.B.S. Marg, Mulund (West), Mumbai - 400080, Maharashtra, India

Tel. No.:

91-22-41577000 

Fax No.:

91-22-41577099

E-Mail :

info@srspharma.com

hr@srspharma.com

mshethco@yahoo.co.in

Website :

http://www.srspharma.com

 

 

Factory :

The Pharmaceutical Prods. of (India) Limited

Plot No. D-312/313, MIDC, Turbhe, Navi Mumbai – 400613, Maharashtra, India

 

 

DIRECTORS

 

AS ON 30.09.2014

 

Name :

Mr. Suchet Shyamsunder Rastogi

Designation :

Director

Address :

B2 - 2202, Floor -22, B2, Beau Monde,, New Prabhadevi Road, Nagusayajiwadi, Prabhadevi, Mumbai - 400025, Maharashtra, India

Date of Birth/Age :

11.05.1977

Date of Appointment :

27.03.2001

PAN No.:

ADMPR6527J

DIN No.:

01161072

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH2001PTC131384

SRS PHARMACEUTICALS PRIVATE LIMITED

Director

27-03-2001

27-03-2001

-

Active

NO

2

U24110MH2005PTC151175

SRS UNISTRAW PRIVATE LIMITED

Director

09-02-2005

09-02-2005

-

Active

NO

3

U24230MH2005PTC151176

CLESSTRA HEALTHCARE PRIVATE LIMITED

Director

09-02-2005

09-02-2005

-

Active

NO

4

U85191MH2006PTC161490

YEVA THERAPEUTICS PRIVATE LIMITED

Director

28-04-2006

28-04-2006

-

Active

NO

5

U24239MH2006PTC162913

UNITEX TENAMYD CANADA PRIVATE LIMITED

Director

29-06-2006

29-06-2006

-

Active

NO

6

U74900HP2010PTC031676

IMMACULE LIFESCIENCES PRIVATE LIMITED

Director

20-09-2010

20-09-2010

-

Active

NO

7

U24233MH2011PTC223522

CARISTAR LABORATORIES PRIVATE LIMITED

Director

31-10-2011

31-10-2011

03-07-2013

Active

NO

8

U15490PN2013PTC147396

KAIA FUNTRITION PRIVATE LIMITED

Director

16-05-2013

16-05-2013

-

Active

NO

 

 

Name :

Mrs. Mahika Suchet Rastogi

Designation :

Director

Address :

2202, Beaumonde, 22nd Floor, Tower B, A. M. Marg, Prabhadevi, Mumbai - 400025, Maharashtra, India

Date of Birth/Age :

24.02.1978

Date of Appointment :

01.01.2013

PAN No.:

ALEPK9173B

DIN No.:

02019780

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH2001PTC131384

SRS PHARMACEUTICALS PRIVATE LIMITED

Director

01-01-2013

04-11-2004

-

Active

NO

2

U24110MH2005PTC151175

SRS UNISTRAW PRIVATE LIMITED

Director

01-01-2013

09-02-2005

-

Active

NO

3

U24230MH2005PTC151176

CLESSTRA HEALTHCARE PRIVATE LIMITED

Director

01-01-2013

09-02-2005

-

Active

NO

4

U85191MH2006PTC161490

YEVA THERAPEUTICS PRIVATE LIMITED

Director

01-01-2013

28-04-2006

-

Active

NO

5

U24239MH2006PTC162913

UNITEX TENAMYD CANADA PRIVATE LIMITED

Director

01-01-2013

29-06-2006

-

Active

NO

6

U74900HP2010PTC031676

IMMACULE LIFESCIENCES PRIVATE LIMITED

Director

01-01-2013

15-07-2011

-

Active

NO

7

U24233MH2011PTC223522

CARISTAR LABORATORIES PRIVATE LIMITED

Director

31-10-2011

31-10-2011

09-01-2012

Active

NO

8

U15490PN2013PTC147396

KAIA FUNTRITION PRIVATE LIMITED

Director

16-05-2013

16-05-2013

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Anjan Shah

Designation :

Finance Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.09.2014

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

Suchet Shyamsunder Rastogi

4950000

99.00

Mahika Suchet Rastogi

50000

1.00

 

 

 

Total

 

5000000

100.00

 

 

 

AS ON 30.09.2014

 

Equity Share Breakup

Percentage of Holding

Category

 

Directors or relatives of directors

100.00

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Supplier of wide range of avant-garde Pharmaceuticals. (Confirmed by Management)

 

 

Products :

ITC Code No.

 

Product Descriptions

30061010

Injections and Capsules

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

 

Products :

Finished Goods

Countries :

·         Vietnam

·         Hong Kong

·         Singapore

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

L/C and Cheque

 

 

Purchasing :

L/C and Cheque

 

 

PRODUCTION STATUS: NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

Customers :

Wholesalers, Retailers and End Users

 

Reference:

Not Divulged

Name of the Person (Designation):

Not Divulged

Contact Number:

Not Divulged

Since how long known:

Not Divulged

Maximum limit dealt:

Not Divulged

Experience:

Not Divulged

Remark

Not Divulged

 

 

No. of Employees :

100 (Approximately)

 

 

Bankers :

Bank Name:

Standard Chartered Bank

Branch:

SME Credit, 23-25 M G Road, Fort, Mumbai - 400001, Maharashtra, India

Person Name (with Designation):

Not Divulged

Contact Number:

91-22-67355687

Name of Account Holder:

SRS Pharmaceuticals Private Limited

Account Number:

22505684167

Account Since (Date/ Year of A/c Opening):

Not Divulged

Average Balance Maintained (Optional):

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan):

Not Divulged

Account Operation:

Not Divulged

Remarks:

Ringing

 

 

Facilities :

SECURED LOANS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

LONG-TERM BORROWINGS

 

 

Rupee term loans from banks

90.660

87.849

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

92.926

60.561

 

 

 

Total

 

183.586

148.410

 

 

 

Auditors :

 

Name :

M. Sheth and Company

Chartered Accountants

Address :

44/C, Motiwala Building , 2nd Floor, Proctor Road, Grant Road (East), Mumbai – 400007, Maharashtra, India

E-Mail :

mshethco@yahoo.co.in

Income-tax PAN of auditor or auditor's firm :

ADUPS7769R

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Subsidiary company :

·         Yeva Therapeutics Private Limited [U85191MH2006PTC161490]

·         Unitex Tenamyd Canada Private Limited [U24239MH2006PTC162913]

·         SRS Unistraw Private Limited [U24110MH2005PTC151175]

·         Clesstra Healthcare Private Limited [U24230MH2005PTC151176]

 

 

Associates :

Immacule Lifesciences Private Limited [U74900HP2010PTC031676]

 

 

Other Related Party :

Unistraw Holding Pte. Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,000,000

Equity Shares

Rs. 10/- each

Rs. 50.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,000,000

Equity Shares

Rs. 10/- each

Rs. 50.000 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

50.000

50.000

50.000

(b) Reserves & Surplus

288.697

227.170

162.589

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

338.697

277.170

212.589

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

90.660

87.849

89.904

(b) Deferred tax liabilities (Net)

5.036

3.031

2.502

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

95.696

90.880

92.406

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

104.812

71.097

45.556

(b) Trade payables

195.821

114.960

63.825

(c) Other current liabilities

9.926

4.855

6.206

(d) Short-term provisions

0.000

10.726

2.770

Total Current Liabilities (4)

310.559

201.638

118.357

 

 

 

 

TOTAL

744.952

569.688

423.352

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

212.528

194.055

193.646

(ii) Intangible Assets

2.765

0.493

0.822

(iii) Capital work-in-progress

0.000

17.821

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

115.070

83.772

5.906

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

17.671

17.528

0.642

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

348.034

313.669

201.016

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

159.795

123.968

67.381

(c) Trade receivables

146.600

75.802

62.791

(d) Cash and cash equivalents

1.397

1.036

0.864

(e) Short-term loans and advances

38.632

17.468

67.760

(f) Other current assets

50.494

37.745

23.540

Total Current Assets

396.918

256.019

222.336

 

 

 

 

TOTAL

744.952

569.688

423.352

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Net Sales

NA

639.613

492.580

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                     (A)

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                     (B)

NA

NA

NA

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

(Including Financial and Depreciation Expenses)

124.294

97.064

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

 

12.163

10.057

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

112.131

87.007

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

16.234

13.687

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

NA

95.897

73.320

 

 

 

 

 

Less

TAX                                                                  (H)

NA

31.317

23.666

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

61.527

64.580

49.654

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of goods calculated on FOB basis

719.453

625.493

NA

 

 

 

 

 

 

Earnings Per Share (Rs.)

12.31

12.92

9.93

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

0.000

2.055

2.419

 

 

 

 

Cash generated from operations

NA

NA

NA

 

 

 

 

Net Cash flow from (used in) Operations

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

NA

10.10

10.08

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

NA

19.43

19.71

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

20.49

17.56

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.35

0.34

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.58

0.58

0.65

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.28

1.27

1.88

 

 

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particulars

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

50.000

50.000

50.000

Reserves & Surplus

162.589

227.170

288.697

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

212.589

277.170

338.697

 

 

 

 

Long-term borrowings

89.904

87.849

90.660

Short term borrowings

45.556

71.097

104.812

CURRENT MATURITIES OF LONG-TERM DEBTS

2.419

2.055

0.000

Total borrowings

137.879

161.001

195.472

Debt/Equity ratio

0.649

0.581

0.577

 

 

 

 

 

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 


 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10591262

16/09/2015

1,500,000.00

STANDARD CHARTERED BANK

SME CREDIT, CRESCENZO, 3A/F, PLOT NO. C-38 & 39, 
G BLOCK, BANDRA KURLA COMPLEX, BANDRA EAST, MUMBAI, MAHARASHTRA - 400051, INDIA

C64355290

2

10191724

15/12/2009

80,000,000.00

STANDARD CHARTERED BANK

STANDARD CHARTERED TOWER, 201 B/1, WESTERN EXPRESS HIGHWAY, GOREGAON (E), MUMBAI, MAHARASHTRA - 400063, INDIA

A74848235

3

90149601

24/09/2014 *

112,500,000.00

STANDARD CHARTERED BANK

SME CREDIT, CRESCENZO, 3A/F, PLOT NO. C-38 & 39, 
G BLOCK, BANDRA KURLA COMPLEX, BANDRA EAST, MUMBAI, MAHARASHTRA - 400051, INDIA

C29568474

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2014

(Rs. In Million)

31.03.2013

(Rs. In Million)

SHORT TERM BORROWINGS

 

 

Loans and advances from related parties

11.886

10.536

 

 

 

Total

 

11.886

10.536

 

FIXED ASSETS:

 

·         Buildings

·         Plant and equipment

·         Furniture and fixtures

·         Vehicles

·         Office equipment

·         Computer equipments

·         Other equipments

·         Computer software

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs. 66.20

UK Pound

1

Rs. 98.30

Euro

1

Rs. 72.41

 

 

INFORMATION DETAILS

 

Information Gathered by :

GYT

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

50

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.